Image

TURN-IT FOG: Improving Turning and Freezing of Gait in People With PD

TURN-IT FOG: Improving Turning and Freezing of Gait in People With PD

Recruiting
50-80 years
All
Phase N/A

Powered by AI

Overview

The goals of this clinical trial are to 1) learn how two different rehabilitation interventions for PD can reduce Freezing of Gait (FOG) in people with Parkinson's disease, as assessed by patients, clinicians, and wearable sensors, and 2) to explore whether two different rehabilitation intervention can reduce FOG and improve daily life mobility in people with FOG sufficiently to justify a clinical trial.

Participants will:

  • Be randomly assigned to one of two intervention groups (turning-focused agility exercise or strength-based exercise)
  • Have one-on-one training sessions three times per week for 6 weeks
  • Perform in-lab assessments before beginning and after completing the study intervention
  • Use wearable mobility sensors during daily life to measure their walking and balance

Eligibility

Inclusion Criteria:

  • diagnosis of idiopathic PD from movement disorders neurologist with the United Kingdom Brain Bank criteria of bradykinesia with one or more of the following - rest tremor, rigidity, and balance problems not from visual, vestibular, cerebellar or proprioceptive conditions
  • reporting FOG in the New Freezing of Gait questionnaire (N-FOGQ)
  • Hoehn & Yahr stages II-IV
  • ages 50-80 years old
  • cognitive ability sufficient to participate in testing procedures and exercise classes
  • be willing and able to participate in exercise intervention 3x/week for 6 weeks

Exclusion Criteria:

  • Major musculoskeletal or neurological disorders, structural brain disease, epilepsy, acute illness or health history, other than PD, significantly affecting gait and turning (i.e., musculoskeletal disorder, vestibular problem, head injury, stroke, cardiac disease)
  • medical condition or medications that precludes moderate-intensity exercise
  • Montreal Cognitive Assessment (MoCA) ≤21 or inability to follow directions
  • excessive use of alcohol or recreational drugs
  • recent change in medication
  • inability to stand and walk for 2 minutes without an assistive device

Study details
    Parkinson Disease
    Freezing of Gait Symptoms in Parkinson Disease

NCT06815302

Oregon Health and Science University

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.